Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Use of monoclonal faecal elastase-1 concentration for pancreatic status assessment in cystic fibrosis patients.

Jornal de pediatria - 1 Jan 2000

Gonzales Andréa C S, Vieira Sandra M G, Maurer Rafael L, Silva Fernando A A e, Silveira Themis R

Abstract excerpt

OBJECTIVE: To assess the concentration of faecal elastase-1 (EL-1) in pediatric patients with cystic fibrosis with mutation DeltaF508. METHODS: Cross-sectional study with samples collected consecutively from 51 patients aged 4 months to 17 years old (mean 9.11±4.74); 32 (62.8%) patients were male. Clinical-demographic data were collected, as well as data on the type of mutation. Exocrine pancreatic insufficiency...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cystic Fibrosis
Share to Epidemiologic Methods

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Exocrine Pancreatic Insufficiency

Share to Heterozygote

Share to Homozygote

Share to Pancreatic Elastase

Share to Reference Values

Source

Identifiers

PMID: 21503378
DOI: 10.2223/JPED.2075

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Use of monoclonal faecal elastase-1 concentration for pancreatic status assessment in cystic fibrosis patients.PMID 21503378Read ↗

Changes in fecal elastase-1 following initiation of CFTR modulator therapy in pediatric patients with cystic fibrosis.Semantic proximity Read ↗

Evaluation of fecal pancreatic elastase-1 as a measure of pancreatic exocrine function in children with cystic fibrosis.Semantic proximity Read ↗

Analysis of exocrine pancreatic function in cystic fibrosis: one mild CFTR mutation does not exclude pancreatic insufficiency.Semantic proximity Read ↗

Fecal elastase: pancreatic status verification and influence on nutritional status in children with cystic fibrosis.Semantic proximity Read ↗

Use of fecal elastase-1 to classify pancreatic status in patients with cystic fibrosis.Semantic proximity Read ↗

The changing face of the exocrine pancreas in cystic fibrosis: the correlation between pancreatic status, pancreatitis and cystic fibrosis genotype.Semantic proximity Read ↗

CFTR modulators increase risk of acute pancreatitis in pancreatic insufficient patients with cystic fibrosis.Semantic proximity Read ↗

[Clinical phenotypes and genotypic spectrum of cystic fibrosis with pancreatic insufficiency in children].Semantic proximity Read ↗

Early decline of pancreatic function in cystic fibrosis patients with class 1 or 2 CFTR mutations.Semantic proximity Read ↗

[Nutrition, cystic fibrosis and the digestive tract].Semantic proximity Read ↗

Cystic fibrosis transmembrane conductance regulator modulators and the exocrine pancreas: A scoping review.Semantic proximity Read ↗

Endocrine and exocrine pancreatic function and the delta F508 mutation in cystic fibrosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.